358 related articles for article (PubMed ID: 34169404)
21. Nervous system consequences of COVID-19.
Spudich S; Nath A
Science; 2022 Jan; 375(6578):267-269. PubMed ID: 35050660
[TBL] [Abstract][Full Text] [Related]
22. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.
De Felice FG; Tovar-Moll F; Moll J; Munoz DP; Ferreira ST
Trends Neurosci; 2020 Jun; 43(6):355-357. PubMed ID: 32359765
[TBL] [Abstract][Full Text] [Related]
23. Chronic long-COVID syndrome: A protracted COVID-19 illness with neurological dysfunctions.
Baig AM
CNS Neurosci Ther; 2021 Dec; 27(12):1433-1436. PubMed ID: 34626096
[TBL] [Abstract][Full Text] [Related]
24. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
[TBL] [Abstract][Full Text] [Related]
25. Clinical and Pathophysiologic Spectrum of Neuro-COVID.
Finsterer J; Scorza FA
Mol Neurobiol; 2021 Aug; 58(8):3787-3791. PubMed ID: 33829393
[TBL] [Abstract][Full Text] [Related]
26. A Comprehensive Review of COVID-19 Associated Neurological Manifestations.
Aggarwal CS; Walser S; Bhandari A; Garg N; McClafferty B; Ramgobin D; Golamari R; Sahu N; Kumar A; Jain R
S D Med; 2020 Dec; 73(12):569-571. PubMed ID: 33684975
[TBL] [Abstract][Full Text] [Related]
27. Emerging neurotropic features of SARS-CoV-2.
Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
[TBL] [Abstract][Full Text] [Related]
28. Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19.
Pantelis C; Jayaram M; Hannan AJ; Wesselingh R; Nithianantharajah J; Wannan CM; Syeda WT; Choy KC; Zantomio D; Christopoulos A; Velakoulis D; O'Brien TJ
Aust N Z J Psychiatry; 2021 Aug; 55(8):750-762. PubMed ID: 32998512
[TBL] [Abstract][Full Text] [Related]
29. Nervous system manifestations related to COVID-19 and their possible mechanisms.
Xie Z; Hui H; Zhao Z; Yu W; Wu R; Zhu Y; Song Y; Cao B; Shi W; Zhao D; Zhao Y; Lv J; Yao Q; Duan Y; Li J; Zhang H; Zhou L; Wang X; Tian Y; Zhao G
Brain Res Bull; 2022 Sep; 187():63-74. PubMed ID: 35772604
[TBL] [Abstract][Full Text] [Related]
30. The Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Development of Case Report Forms for Global Use.
McNett M; Fink EL; Schober M; Mainali S; Helbok R; Robertson CL; Mejia-Mantilla J; Kurtz P; Righy C; Roa JD; Villamizar-Rosales C; Altamirano V; Frontera JA; Maldonado N; Menon D; Suarez J; Chou SHY
Neurocrit Care; 2020 Dec; 33(3):793-828. PubMed ID: 32948987
[TBL] [Abstract][Full Text] [Related]
31. Does COVID-19 contribute to development of neurological disease?
Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
[TBL] [Abstract][Full Text] [Related]
32. [SARS-CoV-2 and neurological disorders: the revelance of biomarkers?].
Bigot-Corbel E; Lanore A; Raulet C; Delorme C; Azulay JP; Lehmann S; Beaudeux JL; Beauvieux MC; Sapin V; Peoc'h K; Rucheton B;
Ann Biol Clin (Paris); 2021 Feb; 79(1):7-16. PubMed ID: 33570039
[TBL] [Abstract][Full Text] [Related]
33. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature.
Siracusa L; Cascio A; Giordano S; Medaglia AA; Restivo GA; Pirrone I; Saia GF; Collura F; Colomba C
Ital J Pediatr; 2021 Jun; 47(1):123. PubMed ID: 34078441
[TBL] [Abstract][Full Text] [Related]
34. Hypercoagulability of COVID-19 and Neurological Complications: A Review.
Moore P; Esmail F; Qin S; Nand S; Berg S
J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106163. PubMed ID: 34763262
[TBL] [Abstract][Full Text] [Related]
35. Peripheral Nervous System Manifestations Associated with COVID-19.
Andalib S; Biller J; Di Napoli M; Moghimi N; McCullough LD; Rubinos CA; O'Hana Nobleza C; Azarpazhooh MR; Catanese L; Elicer I; Jafari M; Liberati F; Camejo C; Torbey M; Divani AA
Curr Neurol Neurosci Rep; 2021 Feb; 21(3):9. PubMed ID: 33586020
[TBL] [Abstract][Full Text] [Related]
36. The Philippine
Espiritu AI; Sy MCC; Anlacan VMM; Jamora RDG
BMJ Open; 2020 Nov; 10(11):e040944. PubMed ID: 33257488
[TBL] [Abstract][Full Text] [Related]
37. NEUROLOGICAL DYSFUNCTION ASSOCIATED WITH COVID-19.
Silva FSCAD; Bucur A; Rosado SN; Balhana SDS; Meneses-Oliveira CM
Rev Bras Ter Intensiva; 2021; 33(2):325. PubMed ID: 34231815
[TBL] [Abstract][Full Text] [Related]
38. Neurological complications of COVID-19: a systematic review.
Taherifard E; Taherifard E
Neurol Res; 2020 Nov; 42(11):905-912. PubMed ID: 32698732
[TBL] [Abstract][Full Text] [Related]
39. Are we sure that the neurological impact of COVID 19 in childhood has not been underestimated?
Principi N; Esposito S
Ital J Pediatr; 2021 Sep; 47(1):191. PubMed ID: 34537061
[TBL] [Abstract][Full Text] [Related]
40. A Comprehensive Review of Neurologic Manifestations of COVID-19 and Management of Pre-existing Neurologic Disorders in Children.
Kim Y; Walser SA; Asghar SJ; Jain R; Mainali G; Kumar A
J Child Neurol; 2021 Mar; 36(4):324-330. PubMed ID: 33112694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
